Hidenao Kayawake1,2, Norihito Okumura3, Keiji Yamanashi1, Yasuhiro Otsuki1, Ayuko Takahashi1, Satoshi Itasaka4, Hiroshige Yoshioka5,6, Takashi Nakashima1, Tomoaki Matsuoka1. 1. Department of Thoracic Surgery, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Okayama, 710-8602, Japan. 2. Department of Thoracic Surgery, Kyoto University, Kyoto, Japan. 3. Department of Thoracic Surgery, Kurashiki Central Hospital, 1-1-1, Miwa, Kurashiki, Okayama, 710-8602, Japan. no7869@kchnet.or.jp. 4. Department of Radiation Therapy, Kurashiki Central Hospital, Okayama, Japan. 5. Department of Respiratory Medicine, Kurashiki Central Hospital, Okayama, Japan. 6. Department of Thoracic Oncology, Kansai Medical University, Osaka, Japan.
Abstract
OBJECTIVES: Although surgical resection after induction therapy (IT) for locally advanced non-small cell lung cancer (NSCLC) is a possible treatment option, pneumonectomy may be avoided owing to high-surgical risks. However, reports exist that pneumonectomy after IT has acceptable safety and favorable outcomes. We reviewed pneumonectomies after IT in terms of surgical outcomes, perioperative management, and complications. METHODS: Between April 2004 and March 2015, 15 consecutive pneumonectomies were performed for locally advanced NSCLC after IT. Surgical outcomes, perioperative management, and complications were retrospectively reviewed. RESULTS: Thirteen patients were men, and 6 pneumonectomies were right-sided. One pneumonectomy was performed after induction chemotherapy and 14 followed induction chemoradiation. In all 15 cases the bronchial stumps were covered with autologous tissues. Pedunculated mediastinal fat pad and pedunculated intercostal muscles were used in 4 and 11 cases, respectively. Although postoperative complications were seen in 12 patients (80.0%), with major complications (Clavien-Dindo classification ≥ IIIa) in 5 patients (33.3%), there were no deaths within 30 days after pneumonectomy. Overall 3- and 5-year survivals were 80.0 and 57.1%, respectively. CONCLUSIONS: Owing to high-surgical risks and complication rates, careful surgical technique and postoperative management are essential for successful pneumonectomy after IT.
OBJECTIVES: Although surgical resection after induction therapy (IT) for locally advanced non-small cell lung cancer (NSCLC) is a possible treatment option, pneumonectomy may be avoided owing to high-surgical risks. However, reports exist that pneumonectomy after IT has acceptable safety and favorable outcomes. We reviewed pneumonectomies after IT in terms of surgical outcomes, perioperative management, and complications. METHODS: Between April 2004 and March 2015, 15 consecutive pneumonectomies were performed for locally advanced NSCLC after IT. Surgical outcomes, perioperative management, and complications were retrospectively reviewed. RESULTS: Thirteen patients were men, and 6 pneumonectomies were right-sided. One pneumonectomy was performed after induction chemotherapy and 14 followed induction chemoradiation. In all 15 cases the bronchial stumps were covered with autologous tissues. Pedunculated mediastinal fat pad and pedunculated intercostal muscles were used in 4 and 11 cases, respectively. Although postoperative complications were seen in 12 patients (80.0%), with major complications (Clavien-Dindo classification ≥ IIIa) in 5 patients (33.3%), there were no deaths within 30 days after pneumonectomy. Overall 3- and 5-year survivals were 80.0 and 57.1%, respectively. CONCLUSIONS: Owing to high-surgical risks and complication rates, careful surgical technique and postoperative management are essential for successful pneumonectomy after IT.
Authors: Matthew Koshy; Stacey A Fedewa; Renu Malik; Mark K Ferguson; Wickii T Vigneswaran; Lawrence Feldman; Andrew Howard; Khaled Abdelhady; Ralph R Weichselbaum; Katherine S Virgo Journal: J Thorac Oncol Date: 2013-07 Impact factor: 15.609
Authors: Anthony W Kim; Michael J Liptay; Philip Bonomi; William H Warren; Sanjib Basu; Erin C Farlow; L Penfield Faber Journal: Ann Thorac Surg Date: 2011-05-28 Impact factor: 4.330
Authors: Stephen R Broderick; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Daniel Morgansztern; Clifford G Robinson; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri Journal: Ann Thorac Surg Date: 2015-09-26 Impact factor: 4.330
Authors: Paul J Speicher; Brian R Englum; Asvin M Ganapathi; Mark W Onaitis; Thomas A D'Amico; Mark F Berry Journal: Eur J Cardiothorac Surg Date: 2014-07-08 Impact factor: 4.191